Indian Journal of Cancer
Home Feedback Subscribe Top cited articles Login
Users Online :96
 Home Email this page Print this page Bookmark this page Small font sizeDefault font sizeIncrease font size
Navigate Here
     My Preferences 
     Manuscript submission
     Back To Article

 
Most popular articles
 
Email Alerts
 
ICS
Article Access Statistics 

Year : 2017 | Volume:  54 | Issue Number:  4 | Page:  664-668

ORIGINAL ARTICLE

A comparative phase III clinical study to evaluate efficacy and safety of TrastuRel™ (biosimilar trastuzumab) and innovator trastuzumab in patients with metastatic human epidermal growth factor receptor 2 (HER2)-overexpressing breast cancer
Apsangikar Prasad, Chaudhry Sunil, Naik Manoj, Deoghare Shashank, Joseph Jamila

Number of times this article was viewed 2860
Number of times this article has been printed  from the site 103
Number of times this article was emailed to others 0
Remarks given by readers [ Read ] 0

 

  Site Map | What's new | Copyright and Disclaimer
  Online since 1st April '07
  2007 - Indian Journal of Cancer | Published by Wolters Kluwer - Medknow